Neurovalens is a medical device that helps provide non-invasive electrical stimulation in the form of a small electrical pulse to treat insomnia and anxiety. A U.S. medical regulator approved this device, a Belfast-based startup that later became a medical device for head-mounted treatment. With technological advancements, this medical device delivers non-invasive therapies to the human nervous system, improving sleep disorders.
Two Neurovalens medical devices have been successfully approved. These devices help to treat insomnia and anxiety. Also, many other devices are becoming ready to treat other disorders like obesity and depression. These devices aim to provide additional healthcare services.
According to the Neurovalens announcement, they secured approximately $2.1 million from investors and raised around $11 million in equity funding from U.K. investors. They also work on various global technologies and neurosciences to treat other health issues. This health tech startup adopts a unique approach to treating specific health conditions.
According to the FDA, the 510K pathway will approve treating GAD as a stress modulation device in the U.S., following the past approval of the Modius Sleep device, which helps treat insomnia. Many other methods for neurostimulation target the brain areas and provide more accurate stimulation.
As Neurovalens utilizes methods to regulate pathways and stimulate cranial nerves with greater non-invasiveness, they have achieved success worldwide. The latest devices, such as Modius Stress, which the FDA has approved, aim to promote wellness for all individuals by enhancing security and health, and preventing various brain and nervous system disorders. Neurovalens started introducing innovative solutions by delivering trials and regulatory clearance. They are not just working and caring for mental health and well-being. They are also trying to invest in more advanced therapies and treatments regarding non-invasive neurostimulation.
